13 completed. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 13 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas loteprednol etabonate 1% arm 1, prednisolone acete 1% - Anterior Chamber Granulomatous Uveitis | Phase 4 | Completed | Fayoum University | 66 | 2025-08-10 | 2026-03-27 |
| Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV) QLETLI - Uveitis | Phase 4 | Completed | Bio-Thera Solutions | 60 | 2021-12-27 | 2026-10-13 |
| Adalimumab in JIA-associated Uveitis Stopping Trial Adalimumab, Placebo - Uveitis, JIA | Phase 4 | Completed | Nisha Acharya | 87 | 2020-03-15 | 2025-05-11 |
| Six-months Versus Nine-months ATT for Ocular TB Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis | Phase 4 | Completed | L.V. Prasad Eye Institute | 58 | 2020-01-01 | 2024-09-26 |
| Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation Lactated Ringer Solution, Normal Saline 0.9% Infusion Solution Bag - Fluid Loss, Symptom Complex, Triple | Phase 4 | Completed | Nicholas M Mohr | 157 | 2017-05-23 | 2018-09-11 |
| A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU Certolizumab Pegol - Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU) | Phase 4 | Completed | UCB Biopharma SRL | 89 | 2016-12-21 | 2026-06-23 |
| Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients H.P. ACTHAR SUBCUTANEOUS GEL INJECTION - Uveitis, Anterior Uveitis | Phase 4 | Completed | Tampa Bay Uveitis Center, LLC | 6 | 2016-06-30 | 2018-07-02 |
| Study of the Effectiveness of Ozurdex for the Control of Uveitis Dexamethasone pellet - Uveitis, Intermediate, Uveitis, Posterior | Phase 4 | Completed | Johns Hopkins University | 20 | 2014-01-01 | 2019-07-05 |
| TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema Ozurdex Intravitreal Injection (0.7 mg) - Macular Edema, Uveitis | Phase 4 | Completed | Northern California Retina Vitreous Associates | 10 | 2013-05-01 | 2015-03-11 |
| Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG travoprost and timolol maleate fixed combination, latanoprost and maleate timolol fixed combination, bimatoprost and timolol maleate fixed combination - Uveitis, Anterior, Cystoid Macular Edema | Phase 4 | Completed | University of Campinas, Brazil | 69 | 2011-10-01 | 2013-11-07 |
| Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis infliximab - Chronic Uveitis | Phase 4 | Completed | Egla C. Rabinovich | 13 | 2007-09-01 | 2013-08-26 |
| Multicenter Uveitis Steroid Treatment (MUST) Trial fluocinolone acetonide intraocular implant, oral corticosteroid with immunosuppressive agents as needed - Uveitis | Phase 4 | Completed | JHSPH Center for Clinical Trials | 255 | 2005-09-01 | 2016-11-25 |
| Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment 0.59 mg Fluocinolone Acetonide implant - Uveitis | Phase 4 | Completed | Duke University | 21 | 2004-03-01 | 2015-03-31 |
Uveitis, Anterior (4) · Macular Edema (3) · Uveitis, Intermediate (3) · Uveitis, Posterior (2) · Axial Spondyloarthritis (1) · Behcet Syndrome (1) · Choroiditis (1) · Emergencies (1) · Eye Abnormalities (1) · Eye Diseases (1) · Glaucoma, Open-Angle (1) · Inflammation (1) · Retinal Vasculitis (1) · Scleritis (1)
Uveal Diseases (13) · Eye Diseases (12) · Panuveitis (7) · Retinal Diseases (4) · Macular Degeneration (3) · Retinal Degeneration (3) · Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Vasculitis (2) · Actinomycetales Infections (1) · Ankylosis (1)
Infliximab (2) · Adalimumab (1) · Adrenal Cortex Hormones (1) · Adrenocorticotropic Hormone (1) · Alkylating Agents (1) · Azathioprine (1) · Bimatoprost (1) · Biological Products (1) · Calcium Dobesilate (1) · Certolizumab Pegol (1) · Chlorambucil (1) · Cyclophosphamide (1) · Cyclosporine (1) · Daclizumab (1) · Dextrans (1)
Bio-Thera Solutions (1) · Duke University (1) · Egla C. Rabinovich (1) · Fayoum University (1) · JHSPH Center for Clinical Trials (1) · Johns Hopkins University (1) · L.V. Prasad Eye Institute (1) · Nicholas M Mohr (1) · Nisha Acharya (1) · Northern California Retina Vitreous Associates (1) · Tampa Bay Uveitis Center, LLC (1) · UCB Biopharma SRL (1) · University of Campinas, Brazil (1)
United States (8) · Australia (2) · United Kingdom (2) · Brazil (1) · Burma (1) · China (1) · Czechia (1) · Egypt (1) · Germany (1) · India (1) · Netherlands (1) · Poland (1) · Spain (1) · Thailand (1)
Alana M Santana, MD (1) · Douglas Jabs, MD, MBA (1) · Egla Rabinovich, MD. MPH (1) · Glenn J Jaffe, MD (1) · Grace L Clarke (1) · Janet T Holbrook, PhD, MPH (1) · Jennifer E Thorne, MD, PhD (1) · John Kempen, MD, PhD (1) · Michael Altaweel, MD (1) · Nisha Acharya, MD MS (1) · Peizeng Yang, M.D (1)
PMID 16406545, PMID 16461435, PMID 16545455, PMID 21652026, PMID 21840602, PMID 21861971, PMID 22247489, PMID 22409563, PMID 23163490, PMID 25115882, PMID 26501236, PMID 26798977, PMID 28477440, PMID 30146446, PMID 32918964, PMID 33854572, PMID 38925285, PMID 39863370, PMID 41919656
2016 (1), U10EY014660 (1), UG1EY029658 (1)